Llama antibodies reportedly reduce harmfulness of COVID-19, could be used as vaccine supplement and treatment agent
Researchers in Belgium said llama antibodies lessen the harmfulness of COVID-19, Reuters reported.
What are the details?
Antibodies were extracted from a llama — whose name is Winter — and the VIB-UGent Center for Medical Biotechnology in Ghent said laboratory testing also revealed that variant virulence was curtailed, the outlet said.
Dominique Tersago — chief medical officer of ExeVir, a VIB-UGent spinoff — said the technology is a potential "game-changer" but would supplement rather than replace vaccines by protecting people with weaker immune systems and treating infected people in hospitals, Reuters said.
Credit: Blaze Media
